Disordered Proteostasis as a Driver of Disease in the Aging Lung

蛋白质稳态紊乱是衰老肺疾病的驱动因素

基本信息

  • 批准号:
    9751135
  • 负责人:
  • 金额:
    $ 199.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-01 至 2020-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The aging lung contributes to the loss of resiliency and frailty in the aging population that impairs the healthspan--reducing the duration of freedom from disability, pain and independence. Interventional strategies to improve healthspan and reduce the social and economic burdens of aging require novel approaches targeting malleable systems that improve resiliency and reduce frailty of the aging lung in response to pathogens and other environmental agents. Proteostasis refers to the dynamic process by which cells control the concentration, conformation, binding interactions, and location of individual proteins making up the proteome through a system of regulated networks. Dysfunction in the proteostasis networks in the cell is a common final pathway in aging phenotypes and declines during aging in model organisms; however, biologically relevant techniques to measure these changes in the mammalian lung and/or examine their consequences for organ physiology have been lacking. The investigators in this PPG have developed novel luminescence- and mass-spectroscopy-based techniques, to measure proteostasis in the lung, which they use to examine the function of the proteostasis networks in the lung during aging and during infection with the influenza A virus, a clinically important model of lung injury. Seasonal and pandemic influenza A infection cause disproportionate morbidity and mortality in older individuals. Severe infection results in the bilateral pulmonary infiltrates and hypoxemia that define the Acute Respiratory Distress Syndrome (ARDS), which is the primary cause of the 20,000-50,000 deaths in patients with influenza A infection each year. The Project Leaders use this system to probe the frailty of the proteostasis networks during aging in three highly integrated Projects and Cores. Project 1 will test the hypothesis that replacement of the tissue-resident alveolar macrophage pool with bone marrow derived alveolar macrophages over the lifespan impairs proteostasis to increase the susceptibility to influenza A infection in aged mice. Project 2 will tst the hypothesis that reducing mitochondrial respiratory chain capacity promotes epithelial proteostasis to attenuate influenza A virus-induced lung injury during aging. Project 3 will test the hypothesis that the enhanced susceptibility of aged, influenza A infected mice to skeletal muscle dysfunction results from an altered balance between signaling from the lung that disrupts proteostasis and signaling from the lung that induces a protective heat shock response. The Project Leaders combine genetic and pharmacologic interventions predicted to enhance or impair proteostatic function in aging mice before and after infection with the influenza A virus with sophisticated assessments of the function of the proteostasis networks (Core B) and lung and skeletal muscle physiology (Core C) to establish causal links between aging, proteostasis, and lung and skeletal muscle dysfunction in a mammalian system, providing important mechanistic and therapeutic insights into human aging.
描述(由申请人提供):老化的肺部会导致老年人口弹性和虚弱的丧失,从而损害健康寿命,从而缩短免于残疾、疼痛和独立的时间。改善健康寿命并减少老龄化社会和经济负担的干预策略需要针对可塑性系统的新方法,以提高弹性并减少衰老肺部对病原体和其他环境因素的脆弱性。蛋白质稳态是指细胞通过调控网络系统控制组成蛋白质组的单个蛋白质的浓度、构象、结合相互作用和位置的动态过程。细胞中蛋白质稳态网络的功能障碍是衰老表型的常见最终途径,并且在模型生物体的衰老过程中会下降;然而,一直缺乏测量哺乳动物肺部这些变化和/或检查其对器官生理学影响的生物学相关技术。该 PPG 的研究人员开发了基于发光和质谱的新型技术来测量肺部的蛋白质稳态,他们用这些技术来检查衰老和甲型流感病毒感染期间肺部蛋白质稳态网络的功能,临床上重要的肺损伤模型。季节性和大流行性甲型流感感染导致老年人发病率和死亡率不成比例。严重感染会导致双侧肺部浸润和低氧血症,从而导致急性呼吸窘迫综合征 (ARDS),这是每年 20,000-50,000 例甲型流感感染患者死亡的主要原因。项目负责人在三个高度集成的项目中使用该系统来探讨衰老过程中蛋白质稳态网络的脆弱性 核心。项目 1 将测试以下假设:在整个生命周期中,用骨髓来源的肺泡巨噬细胞替换组织驻留的肺泡巨噬细胞池会损害蛋白质稳态,从而增加老年小鼠对甲型流感感染的易感性。项目 2 将验证以下假设:减少线粒体呼吸链容量可促进上皮蛋白稳态,从而减轻衰老过程中甲型流感病毒引起的肺损伤。项目 3 将测试以下假设:老年感染甲型流感的小鼠对骨骼肌功能障碍的易感性增强,是由于肺部发出的破坏蛋白质稳态的信号与来自肺部的引发保护性热休克反应的信号之间的平衡改变所致。项目负责人将预测可增强或损害衰老小鼠感染甲型流感病毒前后的蛋白质稳态功能的遗传和药物干预措施与对蛋白质稳态网络(核心 B)以及肺和骨骼肌生理学(核心 C)功能的复杂评估结合起来。 )建立哺乳动物系统中衰老、蛋白质稳态以及肺和骨骼肌功能障碍之间的因果关系,为人类衰老提供重要的机制和治疗见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GR Scott Budinger其他文献

GR Scott Budinger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GR Scott Budinger', 18)}}的其他基金

Targeting abnormal alveolar immune activation and failed epithelial repair in COVID-19
针对 COVID-19 中异常的肺泡免疫激活和失败的上皮修复
  • 批准号:
    10391970
  • 财政年份:
    2022
  • 资助金额:
    $ 199.26万
  • 项目类别:
Targeting abnormal alveolar immune activation and failed epithelial repair in COVID-19
针对 COVID-19 中异常的肺泡免疫激活和失败的上皮修复
  • 批准号:
    10596990
  • 财政年份:
    2022
  • 资助金额:
    $ 199.26万
  • 项目类别:
Microglia mediate cognitive dysfunction in elderly survivors of pneumonia
小胶质细胞介导老年肺炎幸存者的认知功能障碍
  • 批准号:
    10354214
  • 财政年份:
    2022
  • 资助金额:
    $ 199.26万
  • 项目类别:
Project 3: Targeting linear ubiquitination to attenuate inflammation and promote repair after viral pneumonia
项目3:靶向线性泛素化以减轻病毒性肺炎后的炎症并促进修复
  • 批准号:
    10696965
  • 财政年份:
    2021
  • 资助金额:
    $ 199.26万
  • 项目类别:
Project 3: Targeting linear ubiquitination to attenuate inflammation and promote repair after viral pneumonia
项目3:靶向线性泛素化以减轻病毒性肺炎后的炎症并促进修复
  • 批准号:
    10696965
  • 财政年份:
    2021
  • 资助金额:
    $ 199.26万
  • 项目类别:
Project 3: Targeting linear ubiquitination to attenuate inflammation and promote repair after viral pneumonia
项目3:靶向线性泛素化以减轻病毒性肺炎后的炎症并促进修复
  • 批准号:
    10269676
  • 财政年份:
    2021
  • 资助金额:
    $ 199.26万
  • 项目类别:
Alveolar Macrophages as Age-Related Drivers of Disordered Tissue Repair
肺泡巨噬细胞作为紊乱组织修复的年龄相关驱动因素
  • 批准号:
    10417059
  • 财政年份:
    2015
  • 资助金额:
    $ 199.26万
  • 项目类别:
Alveolar Macrophages as Age-Related Drivers of Disordered Tissue Repair
肺泡巨噬细胞作为紊乱组织修复的年龄相关驱动因素
  • 批准号:
    10197742
  • 财政年份:
    2015
  • 资助金额:
    $ 199.26万
  • 项目类别:
Disordered Proteostasis as a Driver of Disease in the Aging Lung
蛋白质稳态紊乱是衰老肺疾病的驱动因素
  • 批准号:
    9779491
  • 财政年份:
    2015
  • 资助金额:
    $ 199.26万
  • 项目类别:
Disordered Proteostasis as a Driver of Disease in the Aging Lung
蛋白质稳态紊乱是衰老肺疾病的驱动因素
  • 批准号:
    10620758
  • 财政年份:
    2015
  • 资助金额:
    $ 199.26万
  • 项目类别:

相似国自然基金

本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目

相似海外基金

Development of a predictive model and electronic health record-based probability scoring system and dashboard for postoperative respiratory failure
开发术后呼吸衰竭的预测模型和基于电子健康记录的概率评分系统和仪表板
  • 批准号:
    10643357
  • 财政年份:
    2023
  • 资助金额:
    $ 199.26万
  • 项目类别:
2/2: PREcision VENTilation to attenuate Ventilation-Induced Lung Injury (PREVENT VILI)
2/2:精确通气以减轻通气引起的肺损伤(预防 VILI)
  • 批准号:
    10738959
  • 财政年份:
    2023
  • 资助金额:
    $ 199.26万
  • 项目类别:
Molecular Phenotyping of ARDS, Pneumonia, and Sepsis using Latent Class Analysis and Metagenomic Sequencing
使用潜在类别分析和宏基因组测序对 ARDS、肺炎和脓毒症进行分子表型分析
  • 批准号:
    10649372
  • 财政年份:
    2023
  • 资助金额:
    $ 199.26万
  • 项目类别:
Preclinical development of a synthetic lung surfactant dry powder aerosol for hypoxemia or acute respiratory distress syndrome patients receiving different modes of ventilation support
用于接受不同通气支持模式的低氧血症或急性呼吸窘迫综合征患者的合成肺表面活性剂干粉气雾剂的临床前开发
  • 批准号:
    10658610
  • 财政年份:
    2023
  • 资助金额:
    $ 199.26万
  • 项目类别:
Immunobiology of the normal and injured lung
正常和受损肺的免疫生物学
  • 批准号:
    10542751
  • 财政年份:
    2022
  • 资助金额:
    $ 199.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了